NCT07769749Not yet recruiting
Basal Stimulation Therapy in Adults With Schizophrenia Requiring Institutional Care
The Impact of Basal Stimulation Therapy in Adult Patients With Schizophrenia Requiring Permanent Institutional Care
Source: ClinicalTrials.gov · Last updated 18 Aug 2026
Brief summary (registry, in English)
The aim of the study is to obtain knowledge of the impact of basal stimulation therapy on the health status of adults suffering from schizophrenia and requiring permanent institutional care. The use of basal stimulation therapy in many European centres for several decades, combined with the limited amount of scientific evidence, justifies undertaking the proposed research. Available evidence indicates reduced anxiety and improved quality of life. No such studies have previously been conducted in institutionalized patients with schizophrenia.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- First submitted
- 26 Jul 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 1 Sept 2027
- Lead sponsor
- The Jerzy Kukuczka Academy of Physical Education in Katowice
- Diseases
- Schizophrenia
- NCT number
- NCT07769749
What you commit to
- Study type: Interventional
- Planned participants: 12
- From 1 Sept 2026 to the primary completion date, 1 Sept 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Study inclusion criteria:
- women and men aged ≥ 55 years,
- consent of the legal guardian/caregiver to participate in the study,
- schizophrenia clinically confirmed for at least 5 years, with predominance of negative symptoms,
- stable drug therapy (treatment unchanged for at least 3 months)
- functional ability of everyday life on the Barthel scale below 40 points.
- The exclusion criteria from the study will be:
- lack of consent to participate in the study;
- pregnancy
- general contraindications (acute inflammatory conditions and diseases accompanied by fever, venous thrombosis, unstable arterial hypertension , early condition after contrast-enhanced computed tomography, early condition after lumbar puncture, general serious condition of the patient )
- exacerbation of the main disease (acute psychosis, severe anxiety, tendency to active aggression, visual seizures)
- active cancer;
- diseases of the nervous system (neuropathies, stroke , damage to the cerebellum, labyrinth) causing altered sensitivity to stimuli;
- diseases and illnesses of the musculoskeletal system that significantly disturb the body's balance and the mobility of the limbs;
- pressure ulcers grade IV and V on the Torrance scale.
Age in the registry: 55 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jerzy Kukuczka Academy of Physical Education in Katowice, Poland Coordinator of this site? Confirm its status | Katowice | Poland | Unknown status |
| Clinical Psychiatric Hospital SPZOZ in Rybnik, Poland Coordinator of this site? Confirm its status | Rybnik | Poland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.